相似文献
1
Response to "Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients".对《延长严重急性呼吸综合征冠状病毒2给药间隔对血液透析患者的影响》的回应
Kidney Int Rep. 2024 Jun 22;9(8):2577-2578. doi: 10.1016/j.ekir.2024.06.025. eCollection 2024 Aug.
2
Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients.延长严重急性呼吸综合征冠状病毒2（SARS-CoV-2）给药间隔对血液透析患者的影响。
Kidney Int Rep. 2024 Jun 24;9(8):2575-2577. doi: 10.1016/j.ekir.2024.04.072. eCollection 2024 Aug.
3
Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.接受血液透析患者接种 1 剂 BNT162b2 疫苗后的短期抗体反应。
CMAJ. 2021 May 31;193(22):E793-E800. doi: 10.1503/cmaj.210673. Epub 2021 May 12.
4
Evaluation of commercial assays for the assessment of SARS-CoV-2 antibody response in hemodialysis patients.评估商业检测试剂盒在评估血液透析患者 SARS-CoV-2 抗体反应中的应用。
Clin Biochem. 2023 Nov;121-122:110681. doi: 10.1016/j.clinbiochem.2023.110681. Epub 2023 Oct 31.
5
Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients.血液透析患者接种新型冠状病毒 2 型疫苗后短期和长期抗体反应减弱。
Vaccines (Basel). 2022 Apr 13;10(4):605. doi: 10.3390/vaccines10040605.
6
[SARS-CoV-2 mRNA-based vaccine in hemodialysis patients: a single center-experience].血液透析患者中基于SARS-CoV-2信使核糖核酸的疫苗：单中心经验
G Ital Nefrol. 2023 Jun 29;40(3):2023-vol3.
7
SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers.感染六个月后血液透析患者与医护人员体内的新型冠状病毒2抗体比较
Int J Nephrol. 2021 Dec 1;2021:4747221. doi: 10.1155/2021/4747221. eCollection 2021.
8
Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.mRNA 或基于载体的 SARS-CoV-2 疫苗首剂在透析患者中的免疫原性：一项多中心前瞻性观察性初步研究。
J Nephrol. 2021 Aug;34(4):975-983. doi: 10.1007/s40620-021-01076-0. Epub 2021 May 29.
9
Humoral response to SARS-CoV-2 vaccination promises to improve the catastrophic prognosis of hemodialysis patients as a result of COVID-19: the COViNEPH Project.SARS-CoV-2 疫苗接种引起的体液免疫反应有望改善 COVID-19 导致的血液透析患者的灾难性预后：COViNEPH 项目。
Pol Arch Intern Med. 2021 Sep 30;131(9):797-801. doi: 10.20452/pamw.16069. Epub 2021 Aug 5.
10
Effect of Third and Fourth mRNA-Based Booster Vaccinations on SARS-CoV-2 Neutralizing Antibody Titer Formation, Risk Factors for Non-Response, and Outcome after SARS-CoV-2 Omicron Breakthrough Infections in Patients on Chronic Hemodialysis: A Prospective Multicenter Cohort Study.基于mRNA的第三剂和第四剂加强疫苗接种对慢性血液透析患者中SARS-CoV-2中和抗体滴度形成、无应答危险因素及SARS-CoV-2奥密克戎突破性感染后结局的影响：一项前瞻性多中心队列研究
J Clin Med. 2022 Jun 2;11(11):3187. doi: 10.3390/jcm11113187.
本文引用的文献
1
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
2
Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid-sparing Immunosuppressive Regimen.接受标准免疫抑制方案与霉酚酸减量免疫抑制方案的肾移植受者在延长的新冠疫苗初级接种系列后的免疫反应比较
Transplant Direct. 2022 Oct 25;8(11):e1393. doi: 10.1097/TXD.0000000000001393. eCollection 2022 Nov.
3
Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain.新冠疫苗加强针在普通人群和合并症患者中的效果。西班牙的一项基于人群的研究。
Environ Res. 2022 Dec;215(Pt 2):114252. doi: 10.1016/j.envres.2022.114252. Epub 2022 Sep 10.
4
Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation.实用肾脏病各阶段疫苗接种指南，包括透析或肾移植患者。
Am J Kidney Dis. 2020 Mar;75(3):417-425. doi: 10.1053/j.ajkd.2019.06.014. Epub 2019 Oct 1.
5
Infectious complications in chronic kidney disease.慢性肾脏病中的感染并发症
Adv Chronic Kidney Dis. 2006 Jul;13(3):199-204. doi: 10.1053/j.ackd.2006.04.004.
Zotero 插件